Antibodies cross blood brain barrier in primates


News provided by Alzheimer’s Society on Wednesday 5th Nov 2014



Antibodies could cross blood brain barriers in primates, according to a study published in Science Translational Medicine today (Wednesday 5 November 2014).

Joy Yu and colleagues have shown that therapeutic antibodies can successfully cross the blood-brain barrier in primates and reduce levels of a toxic protein linked to Alzheimer's disease. The antibody reduces amyloid-beta levels, which is a protein linked to Alzheimer's disease, by binding with receptors and enzymes in the brain to pass the blood-brain barrier.

Alzheimer's Society comment:

Dr Doug Brown, Director of Research at Alzheimer's Society, said:


'The blood-brain barrier acts as a protective layer by stopping some things from passing into the brain from the blood. However, this protection can cause problems for scientists developing drugs for the treatment of neurological diseases, including dementia. These researchers have investigated attaching a potential treatment to a molecule that can pass through the barrier, therefore using this as a sort of passport into the brain. Showing that this works in primates is one step closer to using this technology for treatments in people.


There are very limited drugs available for the treatment of Alzheimer's disease and there is currently no cure for dementia. More research is now needed to see if this also works in the human brain, and whether the drug that makes it into the brain works as an effective treatment for people with Alzheimer's disease.'
- Ends -


Notes to editors:
225,000 will develop dementia this year, that's one every three minutes
Alzheimer's Society research shows that 850,000 people in the UK will have a form of dementia by 2015. In less than ten years a million people will be living with dementia. This will soar to two million people by 2051
Dementia costs the UK economy over £26 Billion per year. This is the equivalent of more than £30,000 per person with dementia.
Alzheimer's Society champions the rights of people living with dementia and the millions of people who care for them
Alzheimer's Society works in England, Wales and Northern Ireland
Alzheimer's Society supports people to live well with dementia today and funds research to find a cure for tomorrow. We rely on voluntary donations to continue our vital work. You can donate now by calling 0845 306 0898 or visiting alzheimers.org.uk
Alzheimer's Society provides a National Dementia Helpline, the number is 0300 222 11 22 or visit alzheimers.org.uk

Press Office 08450 744 395 Email: press@alzheimers.org.uk

Press release distributed by Pressat on behalf of Alzheimer’s Society, on Wednesday 5 November, 2014. For more information subscribe and follow https://pressat.co.uk/


Health
Published By

Alzheimer’s Society

Alzheimer’s Society
press@alzheimers.org.uk
http://alzheimers.org.uk/

Visit Newsroom

Media

No media attached. Please contact Alzheimer’s Society for more information.


Additional PR Formats


You just read:

Antibodies cross blood brain barrier in primates

News from this source: